Get the Stockscreener App
68.69
1.76%
1.19
Pre-market:
69.08
0.39
+0.57%
Netflix Inc stock is traded at $68.69, with a volume of 34.79M.
It is up +1.76% in the last 24 hours and down -12.22% over the past month.
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
See More
Previous Close:
$67.50
Open:
$67.51
24h Volume:
34.79M
Relative Volume:
0.93
Market Cap:
$286.02B
Revenue:
$48.77B
Net Income/Loss:
$13.65B
P/E Ratio:
21.64
EPS:
3.1742
Net Cash Flow:
$11.15B
1W Performance:
-2.29%
1M Performance:
-12.22%
6M Performance:
-30.57%
1Y Performance:
-40.95%
1-Day Range:
$67.31
$68.78
1-Week Range:
$66.54
$70.30
52-Week Range:
$65.08
$124.86
Netflix Inc Stock (NFLX) Company Profile
Name
Netflix Inc
Sector
Industry
Phone
408-540-3700
Address
121 ALBRIGHT WAY, LOS GATOS
Compare NFLX vs DIS, LYV, FOXA, FWONK
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
68.69 | 282.52B | 48.77B | 13.65B | 11.15B | 3.1742 |
DIS
Walt Disney Co
|
104.03 | 176.45B | 97.37B | 12.34B | 7.11B | 6.2499 |
LYV
Live Nation Entertainment Inc
|
171.80 | 39.81B | 25.61B | -229.57M | 1.21B | -1.7628 |
FOXA
Fox Corp
|
62.08 | 26.59B | 16.20B | 1.75B | 2.14B | 3.789 |
FWONK
Liberty Media Corp
|
95.54 | 23.72B | 4.75B | 822.00M | 730.00M | 3.1136 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-27-26 | Downgrade | Erste Group | Buy → Hold |
| Apr-20-26 | Reiterated | Bernstein | Outperform |
| Apr-06-26 | Upgrade | Goldman | Neutral → Buy |
| Mar-30-26 | Initiated | Citizens | Mkt Perform |
| Mar-24-26 | Upgrade | Erste Group | Hold → Buy |
| Mar-18-26 | Resumed | Citigroup | Buy |
| Mar-09-26 | Resumed | Wells Fargo | Equal Weight |
| Mar-02-26 | Resumed | Barclays | Equal Weight |
| Mar-02-26 | Resumed | JP Morgan | Overweight |
| Feb-27-26 | Upgrade | Arete | Neutral → Buy |
| Feb-27-26 | Resumed | Evercore ISI | Outperform |
| Jan-23-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-26 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-26 | Reiterated | Deutsche Bank | Hold |
| Jan-21-26 | Reiterated | Goldman | Neutral |
| Jan-21-26 | Reiterated | Guggenheim | Buy |
| Jan-21-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-21-26 | Reiterated | Morgan Stanley | Overweight |
| Jan-21-26 | Reiterated | Needham | Buy |
| Jan-21-26 | Reiterated | Oppenheimer | Outperform |
| Jan-21-26 | Reiterated | Piper Sandler | Overweight |
| Jan-21-26 | Reiterated | Pivotal Research Group | Hold |
| Jan-21-26 | Reiterated | Rosenblatt | Neutral |
| Jan-21-26 | Reiterated | Rothschild & Co Redburn | Buy |
| Jan-21-26 | Reiterated | TD Cowen | Buy |
| Jan-21-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Wolfe Research | Outperform |
| Jan-12-26 | Initiated | HSBC Securities | Buy |
| Jan-09-26 | Reiterated | Goldman | Neutral |
| Dec-08-25 | Downgrade | Pivotal Research Group | Buy → Hold |
| Dec-08-25 | Downgrade | Rosenblatt | Buy → Neutral |
| Nov-18-25 | Reiterated | Barclays | Equal Weight |
| Oct-31-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-07-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Sep-17-25 | Upgrade | Loop Capital | Hold → Buy |
| Jul-10-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-07-25 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jul-02-25 | Reiterated | Canaccord Genuity | Buy |
| Jul-02-25 | Reiterated | Goldman | Neutral |
| Jun-20-25 | Reiterated | Pivotal Research Group | Buy |
| Jun-12-25 | Reiterated | Oppenheimer | Outperform |
| Jun-03-25 | Reiterated | Jefferies | Buy |
| May-30-25 | Reiterated | BofA Securities | Buy |
| May-19-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-21-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-25 | Reiterated | Barclays | Equal Weight |
| Apr-21-25 | Reiterated | Canaccord Genuity | Buy |
| Apr-21-25 | Reiterated | Guggenheim | Buy |
| Apr-21-25 | Reiterated | JP Morgan | Overweight |
| Apr-21-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-21-25 | Reiterated | MoffettNathanson | Buy |
| Apr-21-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-21-25 | Reiterated | Oppenheimer | Outperform |
| Apr-21-25 | Reiterated | Piper Sandler | Overweight |
| Apr-21-25 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-25 | Reiterated | Wells Fargo | Overweight |
| Apr-17-25 | Resumed | Piper Sandler | Overweight |
| Mar-27-25 | Initiated | FBN Securities | Outperform |
| Mar-17-25 | Upgrade | MoffettNathanson | Neutral → Buy |
| Jan-24-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-23-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-22-25 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-22-25 | Reiterated | Oppenheimer | Outperform |
| Jan-22-25 | Reiterated | Pivotal Research Group | Buy |
| Jan-22-25 | Upgrade | Rosenblatt | Neutral → Buy |
| Jan-22-25 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-16-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Jan-15-25 | Reiterated | BMO Capital Markets | Outperform |
| Jan-15-25 | Reiterated | Oppenheimer | Outperform |
| Jan-08-25 | Reiterated | Goldman | Neutral |
| Jan-06-25 | Reiterated | Argus | Buy |
| Jan-03-25 | Reiterated | The Benchmark Company | Sell |
| Dec-19-24 | Reiterated | UBS | Buy |
| Dec-16-24 | Downgrade | Loop Capital | Buy → Hold |
| Dec-16-24 | Reiterated | Oppenheimer | Outperform |
| Dec-11-24 | Reiterated | JP Morgan | Overweight |
| Nov-20-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-18-24 | Reiterated | Needham | Buy |
| Oct-18-24 | Reiterated | Oppenheimer | Outperform |
| Oct-18-24 | Reiterated | Pivotal Research Group | Buy |
| Oct-16-24 | Reiterated | Loop Capital | Buy |
| Oct-11-24 | Reiterated | Guggenheim | Buy |
| Oct-10-24 | Reiterated | Morgan Stanley | Overweight |
| Oct-10-24 | Reiterated | Oppenheimer | Outperform |
| Oct-07-24 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-07-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-01-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Sep-05-24 | Initiated | China Renaissance | Hold |
| Aug-30-24 | Reiterated | Pivotal Research Group | Buy |
| Jul-17-24 | Reiterated | Guggenheim | Buy |
| Jul-16-24 | Reiterated | The Benchmark Company | Sell |
| Jul-15-24 | Reiterated | BofA Securities | Buy |
| Jul-12-24 | Reiterated | JP Morgan | Overweight |
| Jul-10-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-09-24 | Reiterated | TD Cowen | Buy |
| Jul-02-24 | Reiterated | Argus | Buy |
| May-28-24 | Reiterated | Evercore ISI | Outperform |
| Apr-19-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-19-24 | Upgrade | Needham | Hold → Buy |
| Apr-19-24 | Reiterated | Pivotal Research Group | Buy |
| Apr-15-24 | Reiterated | Deutsche Bank | Hold |
| Apr-12-24 | Reiterated | Morgan Stanley | Overweight |
| Apr-12-24 | Reiterated | Piper Sandler | Neutral |
| Apr-05-24 | Reiterated | Pivotal Research Group | Buy |
| Mar-25-24 | Reiterated | Citigroup | Neutral |
| Mar-12-24 | Reiterated | Jefferies | Buy |
| Mar-11-24 | Reiterated | Oppenheimer | Outperform |
| Jan-30-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Jan-25-24 | Upgrade | DZ Bank | Hold → Buy |
| Jan-24-24 | Reiterated | BMO Capital Markets | Outperform |
| Jan-24-24 | Reiterated | BofA Securities | Buy |
| Jan-24-24 | Reiterated | Canaccord Genuity | Buy |
| Jan-24-24 | Reiterated | Evercore ISI | Outperform |
| Jan-24-24 | Reiterated | Goldman | Neutral |
| Jan-24-24 | Reiterated | Guggenheim | Buy |
| Jan-24-24 | Reiterated | JP Morgan | Overweight |
| Jan-24-24 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-24-24 | Upgrade | Macquarie | Neutral → Outperform |
| Jan-24-24 | Reiterated | Morgan Stanley | Overweight |
| Jan-24-24 | Reiterated | Oppenheimer | Outperform |
| Jan-24-24 | Reiterated | Piper Sandler | Neutral |
| Jan-24-24 | Reiterated | Pivotal Research Group | Buy |
| Jan-24-24 | Reiterated | Redburn Atlantic | Buy |
| Jan-24-24 | Reiterated | Robert W. Baird | Outperform |
| Jan-24-24 | Reiterated | TD Cowen | Outperform |
| Jan-24-24 | Reiterated | UBS | Buy |
| Jan-24-24 | Reiterated | Wells Fargo | Overweight |
| Sep-18-23 | Reiterated | Evercore ISI | Outperform |
| Aug-25-23 | Upgrade | Loop Capital | Hold → Buy |
| Jul-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-17-23 | Reiterated | Deutsche Bank | Buy |
| Jul-13-23 | Reiterated | JP Morgan | Overweight |
| Jul-12-23 | Reiterated | UBS | Buy |
| Jul-05-23 | Upgrade | Goldman | Sell → Neutral |
| Jun-29-23 | Reiterated | Citigroup | Buy |
| Jun-28-23 | Reiterated | Oppenheimer | Outperform |
| Jun-13-23 | Reiterated | BofA Securities | Buy |
| Jun-13-23 | Reiterated | Guggenheim | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Jefferies | Buy |
| Apr-19-23 | Reiterated | Piper Sandler | Neutral |
| Apr-19-23 | Reiterated | Pivotal Research Group | Buy |
| Apr-19-23 | Reiterated | Rosenblatt | Neutral |
| Apr-19-23 | Upgrade | UBS | Neutral → Buy |
| Apr-11-23 | Resumed | Robert W. Baird | Neutral |
| Jan-23-23 | Reiterated | Argus | Buy |
| Jan-20-23 | Reiterated | Canaccord Genuity | Buy |
| Jan-20-23 | Reiterated | Deutsche Bank | Buy |
| Jan-20-23 | Reiterated | Evercore ISI | Outperform |
| Jan-20-23 | Reiterated | Goldman | Sell |
| Jan-20-23 | Reiterated | Guggenheim | Buy |
| Jan-20-23 | Reiterated | Jefferies | Buy |
| Jan-20-23 | Reiterated | MoffettNathanson | Market Perform |
| Jan-20-23 | Reiterated | Oppenheimer | Outperform |
| Jan-20-23 | Reiterated | Piper Sandler | Neutral |
| Jan-20-23 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-23 | Reiterated | Robert W. Baird | Neutral |
| Jan-20-23 | Reiterated | The Benchmark Company | Sell |
| Jan-20-23 | Reiterated | Wedbush | Outperform |
| Jan-20-23 | Reiterated | Wolfe Research | Outperform |
| Jan-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-04-23 | Initiated | New Street | Neutral |
| Dec-29-22 | Upgrade | CFRA | Sell → Buy |
| Dec-14-22 | Reiterated | Jefferies | Hold |
| Dec-09-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-14-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Jun-10-22 | Downgrade | Goldman | Neutral → Sell |
| May-16-22 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-21-22 | Downgrade | DZ Bank | Buy → Hold |
| Apr-21-22 | Downgrade | Edward Jones | Buy → Hold |
| Apr-20-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-20-22 | Downgrade | BofA Securities | Buy → Underperform |
| Apr-20-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-20-22 | Upgrade | Needham | Underperform → Hold |
| Apr-20-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-20-22 | Downgrade | Pivotal Research Group | Buy → Sell |
| Apr-20-22 | Downgrade | Stifel | Buy → Hold |
| Apr-20-22 | Downgrade | UBS | Buy → Neutral |
| Apr-20-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-19-22 | Initiated | Rosenblatt | Neutral |
| Mar-09-22 | Upgrade | Wedbush | Underperform → Neutral |
| Jan-31-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-31-22 | Upgrade | Edward Jones | Hold → Buy |
| Jan-24-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-21-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-21-22 | Reiterated | BofA Securities | Buy |
| Jan-21-22 | Reiterated | Canaccord Genuity | Buy |
| Jan-21-22 | Reiterated | Cowen | Outperform |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Goldman | Neutral |
| Jan-21-22 | Reiterated | Guggenheim | Buy |
| Jan-21-22 | Reiterated | JP Morgan | Overweight |
| Jan-21-22 | Reiterated | MoffettNathanson | Neutral |
| Jan-21-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Jan-21-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-21-22 | Reiterated | Oppenheimer | Outperform |
| Jan-21-22 | Reiterated | Piper Sandler | Overweight |
| Jan-21-22 | Reiterated | Pivotal Research Group | Buy |
| Jan-21-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Upgrade | The Benchmark Company | Sell → Hold |
| Jan-21-22 | Downgrade | Truist | Buy → Hold |
| Jan-21-22 | Reiterated | UBS | Buy |
| Jan-21-22 | Reiterated | Wolfe Research | Outperform |
| Dec-15-21 | Reiterated | The Benchmark Company | Sell |
| Oct-20-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Sep-29-21 | Reiterated | The Benchmark Company | Sell |
| Sep-13-21 | Initiated | Goldman | Neutral |
| Sep-08-21 | Reiterated | JP Morgan | Overweight |
| Sep-07-21 | Reiterated | Atlantic Equities | Overweight |
| Jul-21-21 | Reiterated | Credit Suisse | Outperform |
| Jul-21-21 | Reiterated | Deutsche Bank | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jun-25-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-25-21 | Initiated | Edward Jones | Hold |
| May-19-21 | Resumed | Jefferies | Buy |
| Apr-21-21 | Resumed | Oppenheimer | Outperform |
| Apr-21-21 | Reiterated | Pivotal Research Group | Buy |
| Apr-21-21 | Upgrade | Stifel | Hold → Buy |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Apr-01-21 | Initiated | Piper Sandler | Overweight |
| Mar-25-21 | Reiterated | The Benchmark Company | Sell |
| Mar-23-21 | Upgrade | Argus | Hold → Buy |
| Jan-21-21 | Upgrade | DZ Bank | Hold → Buy |
| Jan-20-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Jan-20-21 | Reiterated | Pivotal Research Group | Buy |
| Jan-20-21 | Reiterated | The Benchmark Company | Sell |
| Jan-20-21 | Upgrade | UBS | Neutral → Buy |
| Jan-20-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-21-20 | Reiterated | BMO Capital Markets | Outperform |
| Oct-21-20 | Reiterated | Bernstein | Outperform |
| Oct-21-20 | Reiterated | Jefferies | Buy |
| Oct-21-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-21-20 | Reiterated | Oppenheimer | Outperform |
| Oct-21-20 | Reiterated | Piper Sandler | Overweight |
| Oct-21-20 | Reiterated | Pivotal Research Group | Buy |
| Oct-21-20 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-21-20 | Reiterated | The Benchmark Company | Sell |
| Oct-21-20 | Reiterated | Wedbush | Underperform |
| Oct-21-20 | Reiterated | Wells Fargo | Equal Weight |
| Oct-16-20 | Reiterated | Morgan Stanley | Overweight |
| Oct-15-20 | Reiterated | Canaccord Genuity | Buy |
| Oct-14-20 | Reiterated | Goldman | Buy |
| Oct-07-20 | Reiterated | Pivotal Research Group | Buy |
| Sep-28-20 | Reiterated | The Benchmark Company | Sell |
| Sep-15-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-20 | Resumed | Raymond James | Mkt Perform |
| Sep-04-20 | Reiterated | The Benchmark Company | Sell |
| Jul-29-20 | Reiterated | Loop Capital | Buy |
View All
Netflix Inc Stock (NFLX) Latest News
Netflix Eyes Theaters for ‘KPop Demon Hunters 2’Netflix (NASDAQ:NFLX) - Benzinga
Naomi Bulochnikov-Paul to Lead Series Comms at Netflix - IMDb
Netflix Has Chased the Best Picture Oscar for Nearly a Decade. Can ‘La Bola Negra’ Finally Win It for the Streamer? - IMDb
Netflix Hires Former Disney Exec Naomi Bulochnikov-Paul as Head of TV Series Communications - IMDb
Disney’s Naomi Bulochnikov-Paul Jumps to Netflix as VP of Series Comms - IMDb
Netflix Loses 'Stranger Things' Creative To Disney in Major Television Deal - IMDb
Ted Sarandos Explains Why the ‘Stranger Things’ Team Left Netflix - The Hollywood Reporter
Rebecca Lowe Joins Netflix’s Broadcast Team for FIFA Women’s World Cup 2027 - IMDb
Netflix, Inc. $NFLX Stock Holdings Reduced by Coastline Trust Co - MarketBeat
Netflix Co-CEO's Growth Concerns Spark Market Reaction, NFLX Dow - GuruFocus
Netflix co-CEO says streaming giant "isn't growing as fast as I want us to" - Proactive financial news
After a Lengthy Slide, It May Be Time to Tune Into a Netflix ETF - ETF Database
Netflix (NASDAQ:NFLX) Stacks Slate With Live Sports - Kalkine Media
Netflix Nabs ‘American Royals’ YA Drama From ‘Red, White & Royal Blue’ Co-Writer Ted Malawer & Alloy Based On Books - IMDb
Ben Affleck used AI ‘for lots of things’ in upcoming Netflix movie - NewsNation
Netflix's Biggest Movie of All Time Set for Major Sequel Shake-Up as Release Strategy Is Confirmed - MovieWeb
Amelia Dimoldenberg to Bring ‘Chicken Shop Date’ Final Season to Netflix and YouTube (EXCLUSIVE) - variety.com
Netflix CEO Says Company’s Growth Not Good Enough: What's Next?Netflix (NASDAQ:NFLX) - Benzinga
Netflix CEO Makes Blunt Admission on Growth - TradingView
Netflix: Decoding The Threat Posed By YouTube (NASDAQ:NFLX) - Seeking Alpha
Ben Affleck Reveals His New Netflix Thriller Movie Uses AI ‘For Lots of Things’ - yahoo.com
Netflix's CEO Just Admitted Growth Isn't Moving Fast Enough - TradingView
East of Eden on Netflix ending, explained: Who dies and how? - netflixlife.com
Ben Affleck Tries to Address Matt Damon's Comments About Making Netflix Action Movies, Admits Using AI for 'Lots of Things' in His New Film - ign.com
Why Is Netflix (NASDAQ:NFLX) Suddenly a Must-Watch Communication Stocks Stock Today? - Kalkine Media
Market movers: Accenture, Micron, Netflix, Nine Mile Metals... - Proactive financial news
Guggenheim raises Netflix stock price target to $80 on valuation By Investing.com - Investing.com Canada
Deutsche Bank upgrades Netflix stock to Buy despite lower target - AD HOC NEWS
Guggenheim raises Netflix stock price target to $80 on valuation - Investing.com
Netflix at Crossroads: Compressed Valuation, Weak Techs - TradingPedia
Netflix’s Problem Isn’t Subscribers, It’s Losing the Attention War - Barchart.com
Netflix CEO Sounds Warning on Growth: 'Not Growing as Fast as I Want' - Yahoo Finance
Guggenheim Adjusts Price Target on Netflix to $80 From $75, Keeps Buy Rating - marketscreener.com
WWE's Netflix Censors Are At It AGAIN (WWE News) - Yahoo Sports
If I Had $10,000 to Invest Today, Here's the Growth Stock I'd Buy Instead of SpaceX - The Motley Fool
Florence Pugh’s Netflix Adaptation Has a New Take on the Question of Where Do Monsters Come From - ign.com
Netflix Co-CEO Voices Growth Concerns Amid Live Content Challenges, NFLX Stock Shows Deep Undervaluation - GuruFocus
Ted Sarandos Has No Regrets Over WB, Talks Overall Deals & Casey Bloys - Deadline
Netflix Co-CEO Sarandos says growth slower than desired, touts live content (NFLX:NASDAQ) - Seeking Alpha
Ben Affleck Used AI “For Lots of Things” in His New Netflix Movie ‘Animals’ - The Hollywood Reporter
Netflix’s Growth Pace Isn’t Meeting Ted Sarandos’ Ambitions - Yahoo Finance
Netflix Stock Drops 40% as Movie Theaters Surge on Blockbusters - 조선일보
Netflix ‘Not Growing as Fast as I Want,’ Co-CEO Sarandos Says - Bloomberg.com
Ted Sarandos Admits Netflix Is "Not Growing as Fast as I Want Us To" - The Hollywood Reporter
How Much Do You Need to Have Netflix, Disney and the 8 Major Streaming Platforms? - Yahoo Finance
Wall Street bank backs Netflix despite U.S. drift to YouTube - Yahoo Finance
Netflix (NASDAQ:NFLX) Stock Price Down 1%Should You Sell? - MarketBeat
Netflix Stock Has Turned $1,000 Into About $654,000 Since Its IPO. It Has Gone Nowhere Since 2021. - Yahoo Finance
Netflix's Content Commitments Rise: Is Cash Flow Under Pressure? - TradingView
What You Need To Know Ahead of Netflix's Earnings Release - Barchart.com
Netflix: 50% Down From All-Time Highs, But Don’t Think Recovery Is Guaranteed Yet (NFLX) - Seeking Alpha
Netflix Inc Stock (NFLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Netflix Inc Stock (NFLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BARTON RICHARD N | Director |
Sep 09 '26 |
Option Exercise |
24.46 |
720 |
17,613 |
3,180 |
| BARTON RICHARD N | Director |
Sep 09 '26 |
Sale |
76.26 |
720 |
54,907 |
2,460 |
| BARTON RICHARD N | Director |
Sep 10 '26 |
Sale |
75.27 |
720 |
54,194 |
2,460 |
0.41%
1.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):